Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Fortress Biotech is an innovative biopharmaceutical company dedicated to acquiring, developing, and commercializing high-potential marketed and development-stage drugs and drug candidates. The company manages a diversified portfolio of over 30 programs across various therapeutic areas, including oncology, rare diseases, and gene therapy, primarily through its network of majority-owned and partner companies. Fortress's business model leverages a world-class business development team to identify and advance promising medical innovations.
Serves as the central hub for Fortress Biotech's corporate strategy, business development, financial management, investor relations, and legal oversight. It orchestrates the company's unique model of acquiring, developing, and commercializing pharmaceutical products through its network of partner companies.
Located in a modern office space within the redeveloped, high-energy Meatpacking District of Manhattan. Its location provides access to a dynamic business environment and talent pool.
Characterized by a fast-paced, entrepreneurial, and results-driven environment. Emphasis is placed on strategic deal-making, scientific innovation through its partner companies, and efficient capital allocation to advance its diverse pipeline.
The NYC headquarters is pivotal for Fortress Biotech's access to global financial markets, leading research institutions, and a rich ecosystem of pharmaceutical and biotech expertise. It serves as the command center for its decentralized R&D model.
Fortress Biotech's global presence is primarily driven by its international business development activities, seeking out and acquiring promising pharmaceutical assets worldwide. While its corporate headquarters are in the U.S., its partner companies conduct clinical trials in various countries, and commercialized products may be marketed internationally through strategic partnerships or direct efforts, thereby extending its operational reach across different global markets.
2 Gansevoort Street, 9th Floor
New York
NY
USA
Address: N/A
N/A - Focus is on subsidiary-specific locations for R&D and operations.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Fortress Biotech' leadership includes:
Fortress Biotech has been backed by several prominent investors over the years, including:
During the past 12 months (May 2023 - May 2024), a key executive change at Fortress Biotech involved the departure of Dr. Lucy Lu, who served as Executive Vice President and Chief Business Officer. No major new executive appointments at the Fortress Biotech corporate level were publicly announced during this period, with the existing core leadership team continuing their roles.
Discover the tools Fortress Biotech uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Fortress Biotech typically utilizes a common corporate email format. Based on publicly available contact information, the predominant structure is the employee's first initial followed by their full last name.
[first_initial][last]@fortressbiotech.com
Format
jjaffe@fortressbiotech.com
Example
90%
Success rate
fortressbiotech.com • May 10, 2024
Fortress Biotech announced its financial results for the first quarter of 2024, providing updates on its revenue, expenses, and financial position. The report also highlighted recent progress within its subsidiary companies, including clinical trial advancements and strategic developments across its diversified pharmaceutical pipeline....more
fortressbiotech.com • April 1, 2024
The company released its comprehensive financial results for the full year ended December 31, 2023. The announcement included key financial metrics and an overview of significant achievements and milestones for Fortress and its partner companies throughout the year....more
fortressbiotech.com • March 12, 2024
Fortress Biotech partner company, Checkpoint Therapeutics, reported positive feedback from the U.S. Food and Drug Administration (FDA) following an End-of-Phase 1 meeting for its lead antibody candidate, cosibelimab, indicating a potentially streamlined path forward for its development in certain cancer indications....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Fortress Biotech, are just a search away.